retatrutide trial news today New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats New data released on weight

Evidence gaps Long-term (5+ year) outcomes data is still being collected

Related GLP-1 Research Guides These supporting pages help build a clear research cluster around GLP-1 research peptides UK, comparison searches and buyer trust

Online pharmacies Online pharmacies offer a convenient way to purchase Ozempic, but its essential to verify that the pharmacy is legitimate and licensed

KFF Health Tracking Poll: The publics views on new prescription weight-loss drugs. October 2024

A separate study from the University of Colorado Anschutz Medical Campus, also using VA data from 21,790 veterans, compared the cardiovascular and kidney safety profiles of three different GLP-1 drugs: liraglutide, semaglutide and dulaglutide

Taking tirzepatide one day early for a single week is a non-event